179 related articles for article (PubMed ID: 34647412)
1. Matrix metalloproteinase-9 inhibition or deletion attenuates portal hypertension in rodents.
Huang HC; Ho HL; Chang CC; Chuang CL; Pun CK; Lee FY; Huang YH; Hou MC; Hsu SJ
J Cell Mol Med; 2021 Nov; 25(21):10073-10087. PubMed ID: 34647412
[TBL] [Abstract][Full Text] [Related]
2. The beneficial effects of curcumin in cirrhotic rats with portal hypertension.
Hsu SJ; Lee JY; Lin TY; Hsieh YH; Huang HC; Lee FY; Lin HC; Hou MC; Lee SD
Biosci Rep; 2017 Dec; 37(6):. PubMed ID: 29162665
[TBL] [Abstract][Full Text] [Related]
3. Insulin reverses major portal hypertension-related derangements in rats with liver cirrhosis and diabetes.
Hsin IF; Huang HC; Chang CC; Hsu SJ; Lee FY; Huo TI; Chuang CL; Hou MC; Lee SD
Clin Sci (Lond); 2018 Nov; 132(22):2391-2405. PubMed ID: 30348829
[TBL] [Abstract][Full Text] [Related]
4. Cannabinoid receptor 2 agonist ameliorates mesenteric angiogenesis and portosystemic collaterals in cirrhotic rats.
Huang HC; Wang SS; Hsin IF; Chang CC; Lee FY; Lin HC; Chuang CL; Lee JY; Hsieh HG; Lee SD
Hepatology; 2012 Jul; 56(1):248-58. PubMed ID: 22290687
[TBL] [Abstract][Full Text] [Related]
5. Glycyrrhizin Attenuates Portal Hypertension and Collateral Shunting via Inhibition of Extrahepatic Angiogenesis in Cirrhotic Rats.
Pun CK; Huang HC; Chang CC; Chuang CL; Yen CH; Hsu SJ; Lee FY; Hou MC; Huang YH
Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299285
[TBL] [Abstract][Full Text] [Related]
6. Green tea polyphenol decreases the severity of portosystemic collaterals and mesenteric angiogenesis in rats with liver cirrhosis.
Hsu SJ; Wang SS; Hsin IF; Lee FY; Huang HC; Huo TI; Lee WS; Lin HC; Lee SD
Clin Sci (Lond); 2014 May; 126(9):633-44. PubMed ID: 24063570
[TBL] [Abstract][Full Text] [Related]
7. Microbiota transplants from feces or gut content attenuated portal hypertension and portosystemic collaterals in cirrhotic rats.
Huang HC; Tsai MH; Chang CC; Pun CK; Huang YH; Hou MC; Lee FY; Hsu SJ
Clin Sci (Lond); 2021 Dec; 135(24):2709-2728. PubMed ID: 34870313
[TBL] [Abstract][Full Text] [Related]
8. Cediranib ameliorates portal hypertensive syndrome via inhibition of VEGFR-2 signaling in cirrhotic rats.
Fan Q; Wu G; Chen M; Luo G; Wu Z; Huo H; Li H; Zheng L; Luo M
Eur J Pharmacol; 2024 Feb; 964():176278. PubMed ID: 38158116
[TBL] [Abstract][Full Text] [Related]
9. Glucobrassicin Metabolites Ameliorate the Development of Portal Hypertension and Cirrhosis in Bile Duct-Ligated Rats.
Chang T; Ho HL; Hsu SJ; Chang CC; Tsai MH; Huo TI; Huang HC; Lee FY; Hou MC; Lee SD
Int J Mol Sci; 2019 Aug; 20(17):. PubMed ID: 31454890
[TBL] [Abstract][Full Text] [Related]
10. Extrahepatic angiogenesis hinders recovery of portal hypertension and collaterals in rats with cirrhosis resolution.
Hsu SJ; Tsai MH; Chang CC; Hsieh YH; Huang HC; Lee FY; Chuang CL; Hou MC; Lee SD
Clin Sci (Lond); 2018 Mar; 132(6):669-683. PubMed ID: 29449343
[TBL] [Abstract][Full Text] [Related]
11. Endothelin receptor blockers reduce shunting and angiogenesis in cirrhotic rats.
Hsu SJ; Lin TY; Wang SS; Chuang CL; Lee FY; Huang HC; Hsin IF; Lee JY; Lin HC; Lee SD
Eur J Clin Invest; 2016 Jun; 46(6):572-80. PubMed ID: 27091078
[TBL] [Abstract][Full Text] [Related]
12. Pioglitazone decreases portosystemic shunting by modulating inflammation and angiogenesis in cirrhotic and non-cirrhotic portal hypertensive rats.
Schwabl P; Payer BA; Grahovac J; Klein S; Horvatits T; Mitterhauser M; Stift J; Boucher Y; Trebicka J; Trauner M; Angermayr B; Fuhrmann V; Reiberger T; Peck-Radosavljevic M
J Hepatol; 2014 Jun; 60(6):1135-42. PubMed ID: 24530596
[TBL] [Abstract][Full Text] [Related]
13. Reversal of portal hypertension and hyperdynamic splanchnic circulation by combined vascular endothelial growth factor and platelet-derived growth factor blockade in rats.
Fernandez M; Mejias M; Garcia-Pras E; Mendez R; Garcia-Pagan JC; Bosch J
Hepatology; 2007 Oct; 46(4):1208-17. PubMed ID: 17654489
[TBL] [Abstract][Full Text] [Related]
14. Nucleos(t)ide Analogs Do Not Independently Influence Hepatic Fibrosis and Portal Hypertension beyond Viral Suppression in CBDL-Induced Cirrhotic Rat.
Hsieh YH; Huang HC; Chang CC; Chuang CL; Lee FY; Hsu SJ; Huang YH; Hou MC; Lee SD
J Pharmacol Exp Ther; 2018 Nov; 367(2):260-266. PubMed ID: 30194095
[TBL] [Abstract][Full Text] [Related]
15. Folic acid ameliorates homocysteine-induced angiogenesis and portosystemic collaterals in cirrhotic rats.
Ho HL; Tsai MH; Hsieh YH; Huo TI; Chang CC; Lee FY; Huang HC; Hou MC; Lee SD
Ann Hepatol; 2019; 18(4):633-639. PubMed ID: 31078441
[TBL] [Abstract][Full Text] [Related]
16. The Beneficial Effects of P2X7 Antagonism in Rats with Bile Duct Ligation-induced Cirrhosis.
Tung HC; Lee FY; Wang SS; Tsai MH; Lee JY; Huo TI; Huang HC; Chuang CL; Lin HC; Lee SD
PLoS One; 2015; 10(5):e0124654. PubMed ID: 25933224
[TBL] [Abstract][Full Text] [Related]
17. The Impact of Spironolactone on the Severity of Portal-Systemic Collaterals and Hepatic Encephalopathy in Cirrhotic Rats.
Hsu SJ; Wang SS; Huo TI; Lee FY; Huang HC; Chang CC; Hsin IF; Ho HL; Lin HC; Lee SD
J Pharmacol Exp Ther; 2015 Oct; 355(1):117-24. PubMed ID: 26260462
[TBL] [Abstract][Full Text] [Related]
18. Caffeine ameliorates hemodynamic derangements and portosystemic collaterals in cirrhotic rats.
Hsu SJ; Lee FY; Wang SS; Hsin IF; Lin TY; Huang HC; Chang CC; Chuang CL; Ho HL; Lin HC; Lee SD
Hepatology; 2015 May; 61(5):1672-84. PubMed ID: 25557829
[TBL] [Abstract][Full Text] [Related]
19. 2'-Hydroxyflavanone ameliorates mesenteric angiogenesis and portal-systemic collaterals in rats with liver fibrosis.
Hsin IF; Lee JY; Huo TI; Lee FY; Huang HC; Hsu SJ; Wang SS; Ho HL; Lin HC; Lee SD
J Gastroenterol Hepatol; 2016 May; 31(5):1045-51. PubMed ID: 26474184
[TBL] [Abstract][Full Text] [Related]
20. Ascorbate lacks significant influence in rats with bile duct ligation-induced liver injury.
Ho HL; Huo TI; Chang T; Lee WS; Hsin IF; Lee FY; Huang HC; Hou MC; Lee SD
J Chin Med Assoc; 2017 Sep; 80(9):539-550. PubMed ID: 28684188
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
